There are buying opportunities in biotech and drug stocks despite the backlash from the repeal of Obamacare.

The Inside ETF conference has begun, and by all accounts it is the biggest yet. Here’s what attendees will be talking about.

If the dollar keeps rising, investors may want to rethink consumer staples in their portfolios.

For investors looking to start 2017 with a bang, Netflix and Facebook might be the stocks to buy out of the so-called FANGs.

The game has changed for investors in high-yield dividend-paying stocks. They no longer have the wind at their backs.

It’s complicated, but one trader makes it simple: He’s betting on pre-inauguration volatility.

Wealthy Americans are pumped about Trump and are planning major changes to their investment portfolios: CNBC Millionaire Survey.

Many perceive hedge funds to be a risky investment, yet some advisors see a strong upside to employing hedged strategies.

Here’s how to survive if the Federal Reserve raises rates next month and the incoming Trump administration stimulates the economy by borrowing money.

Relying on common sense and market conventions are among the causes of a list of seven mistakes often made by investors, according to the investment house AMP Capital.

Advisors say building a passive investment portfolio involves more than simply plowing cash into one passively managed fund.

Exchange-traded funds may be ‘cool’ among young investors, but advisors warn that they should be vetted as thoroughly as any mutual fund.

Factor investing, accessed via smart beta ETFs, identifies factors offering excess or differentiated returns when targeted in a strategy.

Investors shouldn’t forget about these important factors when investing this summer, two analysts say.

A recent study shows that investors have figured out a way around the passive versus active management debate.